Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 10.38%422.38K | 101.45%460.8K | 43.85%448.96K | 37.28%1.36M | 80.51%436.74K | 81.38%382.67K | -8.64%228.75K | 8.53%312.11K | 56.28%990.88K | -28.99%241.94K |
| Selling and administrative expenses | -16.00%243.61K | 40.54%256.2K | 7.92%288.46K | 27.37%1.07M | 77.96%326.3K | 58.48%289.99K | -16.60%182.3K | 6.12%267.29K | 58.62%836.81K | -39.11%183.36K |
| -Selling and marketing expense | 0.13%30.28K | -3.60%30.19K | -1.15%31.74K | 6.09%128.2K | 11.96%34.53K | 0.82%30.25K | 4.38%31.31K | 7.04%32.11K | 95.47%120.84K | 2.80%30.84K |
| -General and administrative expense | -17.87%213.32K | 49.69%226.01K | 9.16%256.71K | 30.97%937.67K | 91.30%291.77K | 69.78%259.75K | -19.94%150.99K | 5.99%235.17K | 53.73%715.97K | -43.74%152.52K |
| Other operating expenses | 92.91%178.77K | 340.51%204.61K | 258.08%160.5K | 91.07%294.39K | 88.51%110.44K | 231.09%92.67K | 46.08%46.45K | 25.57%44.82K | 44.67%154.07K | 47.95%58.59K |
| Operating profit | -10.38%-422.38K | -101.45%-460.8K | -43.85%-448.96K | -37.28%-1.36M | -80.51%-436.74K | -81.38%-382.67K | 8.64%-228.75K | -8.53%-312.11K | -56.28%-990.88K | 28.99%-241.94K |
| Net non-operating interest income (expenses) | -99.90%30 | -99.47%212 | -99.49%134 | 84.94K | -11.95K | 30.6K | 40.08K | 26.21K | 0 | 0 |
| Non-operating interest income | -99.90%30 | -99.47%212 | -99.49%134 | --84.94K | ---11.95K | --30.6K | --40.08K | --26.21K | --0 | --0 |
| Other net income (expenses) | -5,107.29%-14.21M | -164.24%-33.61K | -137.83%-6.23K | 243.20%420.17K | 142.24%67.68K | 252.02%283.71K | 125.83%52.32K | 246.58%16.46K | -673.08%-293.42K | -314.36%-160.22K |
| Gain on sale of security | -81.31%53.03K | -164.24%-33.61K | -137.83%-6.23K | 377.80%420.17K | 138.85%67.68K | 3,884.73%283.71K | 93.15%52.32K | 246.58%16.46K | -298.50%-151.25K | -350.60%-174.23K |
| Special income (charges) | ---14.26M | ---- | ---- | --0 | --0 | --0 | --0 | ---- | ---142.17K | --14.01K |
| -Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- | ---87.49K | ---14.01K |
| -Less:Impairment of capital assets | --14.26M | ---- | ---- | --0 | --0 | --0 | --0 | ---- | --229.66K | --0 |
| Income before tax | -21,302.27%-14.63M | -262.44%-494.2K | -68.89%-455.05K | 33.42%-855.15K | 5.26%-381K | 47.58%-68.35K | 69.90%-136.36K | 9.83%-269.44K | -91.12%-1.28M | -6.00%-402.16K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -21,302.27%-14.63M | -262.44%-494.2K | -68.89%-455.05K | 33.42%-855.15K | 5.26%-381K | 47.58%-68.35K | 69.90%-136.36K | 9.83%-269.44K | -91.12%-1.28M | -6.00%-402.16K |
| Net income continuous operations | -21,302.27%-14.63M | -262.44%-494.2K | -68.89%-455.05K | 33.42%-855.15K | 5.26%-381K | 47.58%-68.35K | 69.90%-136.36K | 9.83%-269.44K | -91.12%-1.28M | -6.00%-402.16K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -21,302.27%-14.63M | -262.44%-494.2K | -68.89%-455.05K | 33.42%-855.15K | 5.26%-381K | 47.58%-68.35K | 69.90%-136.36K | 9.83%-269.44K | -91.12%-1.28M | -6.00%-402.16K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -21,302.27%-14.63M | -262.44%-494.2K | -68.89%-455.05K | 33.42%-855.15K | 5.26%-381K | 47.58%-68.35K | 69.90%-136.36K | 9.83%-269.44K | -91.12%-1.28M | -6.00%-402.16K |
| Diluted earnings per share | -0.28 | -0.01 | 0.00%-0.01 | 50.00%-0.02 | 0.00%-0.01 | 0 | 0 | 0.00%-0.01 | -33.33%-0.04 | 42.27%-0.01 |
| Basic earnings per share | -0.28 | -0.01 | 0.00%-0.01 | 50.00%-0.02 | 0.00%-0.01 | 0 | 0 | 0.00%-0.01 | -33.33%-0.04 | 42.27%-0.01 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.